-
How to interpret clinical trial results for Long COVID
With no proven treatments or cures, many people with Long COVID are turning to off-label medications, supplements, and medical devices to treat their symptoms. There are numerous options — and some of them even have clinical trials underway or are reporting results. But even if one study suggests a treatment might work, another might contradict it. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSTrending
Policy & Advocacy
-
Kennedy’s HHS commits to Long COVID, but without clear funding
-
How do you get people to care about COVID-19? Here’s what I’ve learned as an organizer.
-
Left without care: Many Long COVID clinics are closing down in the U.K.
-
The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID.
-
Long COVID is increasing housing insecurity, but support programs fail to help
-
Minnesota’s unique Long COVID program retains funding following advocacy
Science
Covid-19
Health
-
The future of Medicaid is “really scary” for people with Long COVID
-
International Long COVID conference spotlights biomarker and mechanism research
-
Less than 20% of Long COVID trials involving exercise even mention post-exertional malaise
-
Alice Wong, disability activist and luminary, dies at 51
-
As the American West faces increasing air pollution, protecting the right to mask is vital
-
Business school competition centers Long COVID and IACCs
-
The trouble with recovery stories
-
We set out to make our ‘invisible illness’ visible in South Africa with SICK Pride
-
Why aren’t public health officials telling people about the fertility cost of COVID-19 and Long COVID?
-
Five reasons why the NIH should retract the “effort preference” claims in their intramural ME/CFS paper